Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Skin cancer and Trametinib

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Skin cancer and Trametinib

Skin cancer vs. Trametinib

Skin cancers are cancers that arise from the skin. Trametinib (trade name Mekinist) is a cancer drug.

Similarities between Skin cancer and Trametinib

Skin cancer and Trametinib have 4 things in common (in Unionpedia): BRAF (gene), Dabrafenib, MEK inhibitor, Melanoma.

BRAF (gene)

BRAF is a human gene that encodes a protein called B-Raf.

BRAF (gene) and Skin cancer · BRAF (gene) and Trametinib · See more »

Dabrafenib

Dabrafenib (trade name Tafinlar, GSK2118436) is a drug for the treatment of cancers associated with a mutated version of the gene BRAF.

Dabrafenib and Skin cancer · Dabrafenib and Trametinib · See more »

MEK inhibitor

A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.

MEK inhibitor and Skin cancer · MEK inhibitor and Trametinib · See more »

Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes.

Melanoma and Skin cancer · Melanoma and Trametinib · See more »

The list above answers the following questions

Skin cancer and Trametinib Comparison

Skin cancer has 94 relations, while Trametinib has 14. As they have in common 4, the Jaccard index is 3.70% = 4 / (94 + 14).

References

This article shows the relationship between Skin cancer and Trametinib. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »